immunotherapy in the neoadjuvant management of her2-positive breast cancer
Published 3 years ago • 105 plays • Length 3:52Download video MP4
Download video MP3
Similar videos
-
1:00
utilizing neoadjuvant immunotherapies in patients with er , her2- primary breast cancer
-
22:50
neoadjuvant therapy for her2-positive breast cancer - dr. scott christensen
-
4:27
study of immunotherapy combinations for patients with her2-positive metastatic breast cancer
-
9:02
novel therapies in the management of her2-positive breast cancer
-
1:33
dr. rimawi on the clinical need for immunotherapy in her2-positive breast cancer
-
6:25
neoadjuvant and adjuvant therapy for her2-positive breast cancer
-
1:49
immunotherapy and beyond for lung cancer prevention
-
3:28
neoadjuvant treatment strategies for her2-positive breast cancer
-
7:18
advances in management of her2-positive breast cancer
-
1:06
immunotherapy combination in her2-positive breast cancer
-
22:27
tumor-immune microenvironment during neoadjuvant targeted therapy in her2-positive breast cancer
-
13:08
her2 positive breast cancer: everything you must know
-
0:34
future role of immunotherapy in her2 breast cancer
-
1:24
treatment de-escalation and escalation strategies in her2-positive breast cancer
-
3:01
alternate: neoadjuvant chemotherapy in er her2- breast cancer
-
4:50
overview of neoadjuvant therapy in her2 breast cancer
-
31:24
harnessing the immune system in the treatment of triple-negative breast cancer
-
6:54
key clinical trials investigating immunotherapy in her2 and hr breast cancer
-
1:25
dr. tolaney on the neoadjuvant therapy for her2-positive breast cancer